Deutsche Märkte geschlossen

Boston Scientific Corporation (BSX)

NYSE - Nasdaq Echtzeitpreis. Währung in USD
Zur Watchlist hinzufügen
38,73-0,61 (-1,55%)
Börsenschluss: 04:00PM EDT
38,73 0,00 (0,00%)
Nachbörse: 05:59PM EDT

Boston Scientific Corporation

300 Boston Scientific Way
Marlborough, MA 01752-1234
United States
508 683 4000
https://www.bostonscientific.com

Sektor(en)Healthcare
BrancheMedical Devices
Vollzeitmitarbeiter41.000

Leitende Angestellte

NameTitelZahlenAusgeübtGeburtsjahr
Mr. Michael F. MahoneyChairman, Pres & CEO3,83MN/A1965
Mr. Daniel J. BrennanExec. VP & CFO1,4M796,81k1966
Mr. Joseph M. FitzgeraldExec. VP & Group Pres of Cardiology1,57M2,72M1964
Mr. Jeffrey B. MirvissExec. VP & Pres of Peripheral Interventions1,21M2,75M1966
Mr. John Bradley SorensonExec. VP of Global OperationsN/AN/A1968
Mr. Jonathan R MonsonVP, Global Controller & Chief Accounting OfficerN/AN/AN/A
Ms. Jodi Euerle EddySr. VP and Chief Information & Digital OfficerN/AN/A1973
Ms. Susan Vissers LisaVP of Investor RelationsN/AN/A1969
Mr. Vance R. BrownSr. VP, Gen. Counsel & Corp. Sec.N/AN/AN/A
Ms. Catherine JenningsVP of Global Marketing & New Bus. Devel. of Peripheral InterventionsN/AN/AN/A
Die Beträge haben den Stand 31. Dezember 2021 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Corporate Governance

Boston Scientific Corporations ISS Governance QualityScore, Stand 1. September 2022, lautet 7. Die grundlegenden Scores sind Audit: 9, Vorstand: 7, Shareholderrechte: 7, Kompensation: 6.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.